38
https://pubmed.ncbi.nlm.nih.gov/38091917
This study found that in individuals with premenstrual dysphoric disorder (PMDD), sertraline treatment was associated with a significant increase in luteal phase serum pregnanolone levels and a significantly increased pregnanolone:progesterone ratio.
